Dima D, Jogia J, Collier D, Vassos E, Burdick KE, Frangou S. CACNA1C and ANK3 risk-genes for bipolar disorder independently
modulate engagement and connectivity of the face network during affect processing. JAMA Psychiatry. 2013;70 (12):1303-11. PMID: 24108394
Frangou S. Snipping at the endophenotypic space. Am J Psychiatry. 2013; 170(11): 1223-5. PMID: 24185234
Papachristou E, Ormel J, Oldehinkel AJ, Kyriakopoulos M, Reinares M, Reichenberg A, Frangou S. Child Behavior
Checklist—Mania Scale (CBCL-MS): Development and Evaluation of a Population-Based Screening Scale for Bipolar Disorder. PLoS ONE 8(8): e69459 PMID: 23967059
Papachristou E, Frangou S, Reichenberg A. Expanding conceptual frameworks: Life course risk modelling for mental disorders.
Psychiatry Res 206(2-3):140-5. PMID: 23127538
Frangou S. Neurocognition in early-onset schizophrenia. Child Adolesc Psychiatr Clin N Am. 2013;22(4):715-26. PMID:
24012082
Delvecchio G, Sugranyes G, Frangou S. Evidence of diagnostic specificity in the neural correlates of facial affect processing
in bipolar disorder and schizophrenia: a meta-analysis of functional imaging studies. Psychol Med. 2013; 43(3):553-69. PMID: 22874625
Brambilla P, Perlini C, Bellani M, Tomelleri L, Ferro A, Cerruti S, Marinelli V, Rambaldelli G, Christodoulou T, Jogia J, Dima
D, Tansella M, Balestrieri M, Frangou S. Increased salience of gains versus decreased associative learning differentiate bipolar disorder from schizophrenia during incentive decision making.
Psychol Med. 2013; 43(3):571-80. PMID: 22687364
Reinares M,
Papachristou E, Harvey P, Mar Bonnín C, Sánchez-Moreno J, Torrent C, Ayuso-Mateos JL, Ploubidis GB, Vieta E, Frangou S. Towards a clinical staging for bipolar disorder: Defining patient subtypes
based on functional outcome. J Affect Disord. 2013; 144(1-2):65-71.
Reinares M, Rosa AR, Franco C, Goikolea JM, Fountoulakis K, Siamouli M, Gonda X, Frangou S, Vieta E. A systematic review on
the role of anticonvulsants in the treatment of acute bipolar depression. Int J Neuropsychopharmacol. 2013;16(2):485-96. PMID: 22575611
Cheema N, Frangou S, McCrone P. Cost-effectiveness of ethyl-eicosapentaenoic acid in the treatment of bipolar
disorder. Ther Adv Psychopharmacol. 2013;3(2):73-81. PMID: 24167678
Frey BN, Andreazza AC, Houenou J, Jamain S,
Goldstein BI, Frye MA, Leboyer M, Berk M, Malhi GS, Lopez-Jaramillo C, Taylor VH, Dodd S, Frangou S, Hall GB, Fernandes BS, Kauer-Sant'anna M, Yatham LN, Kapczinski F, Young LT. Biomarkers in bipolar
disorder: A positional paper from the International Society for Bipolar Disorders Biomarkers Task Force. Aust N Z J Psychiatry 47(4):321-32. PMID: 23411094
Print 